Plasma exchange treats severe intrahepatic cholestasis caused by dacomitinib: A case report
RATIONALE: Dacomitinib-induced liver injury is often manifested by mild elevations of transaminases and bilirubin, and severe intrahepatic cholestasis caused by dacomitinib for simultaneous taking orally cytochrome P450 2D6 (CYP2D6) competitive substrates has been rarely reported. PATIENT CONCERNS:...
Main Authors: | Chen, Q. (Author), Fang, N. (Author), Lu, W. (Author), Qiao, F. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
NLM (Medline)
2022
|
Online Access: | View Fulltext in Publisher |
Similar Items
-
Sepsis as a cause of intrahepatic cholestasis
by: Rudić Jelena, et al.
Published: (2009-01-01) -
Intrahepatic cholestasis
by: Richard Thompson
Published: (2016-01-01) -
Intrahepatic cholestasis of pregnancy
by: Beuers Ulrich, et al.
Published: (2007-05-01) -
Intrahepatic cholestasis in pregnancy
by: Savić Ž., et al.
Published: (2014-01-01) -
Glucocorticoid treatment of intrahepatic cholestasis caused by infectious cholangitis: A case report
by: ZHAO Youyou
Published: (2019-02-01)